Inspire Medical Systems
INSP
148 hedge funds and large institutions have $1.21B invested in Inspire Medical Systems in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 37 reducing their positions, and 18 closing their positions.
678% more call options, than puts
Call options by funds: $16.9M | Put options by funds: $2.17M
57% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 37
50% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 18
20% more capital invested
Capital invested by funds: $1.01B → $1.21B (+$200M)
7.95% more ownership
Funds ownership: 75.92% → 83.87% (+7.9%)
3% more funds holding
Funds holding: 143 → 148 (+5)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$38.3M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$25.1M |
| 3 |
BlackRock
New York
|
+$23M |
| 4 |
CCI
Columbus Circle Investors
|
+$21.6M |
| 5 |
BAMCO Inc
New York
|
+$12.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$36.9M |
| 2 |
Millennium Management
New York
|
-$14.4M |
| 3 |
Two Sigma Investments
New York
|
-$8.17M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.89M |
| 5 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$4.3M |
INSP Hedge Fund Activity: Q2 2019 in Review
148 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q2 2019, worth a combined $1.21B — up 20% from $1.01B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new INSP positions and 18 closed out — a net gain of 9 holders — while 58 added to existing stakes and 37 trimmed.
The largest buyer was Invesco, adding an estimated $38.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $36.9M.
- 148 institutional investors held Inspire Medical Systems (INSP) as of Q2 2019, up from 143 in Q1 2019.
- Funds reported $1.21B of Inspire Medical Systems stock for Q2 2019, up 20% quarter-over-quarter.
- 27 funds opened new Inspire Medical Systems positions in Q2 2019 and 18 closed out, a net change of +9 holders.
- The largest Inspire Medical Systems buyer in Q2 2019 was Invesco, an estimated $38.3M added.
- The largest Inspire Medical Systems seller in Q2 2019 was T. Rowe Price Associates, an estimated $36.9M sold.
Based on aggregated 13F filings for Q2 2019.